Every weight-loss figure quoted across this entire category — roughly 15% for semaglutide, roughly 21% for tirzepatide — comes from trials run on the approved products. Compounded sellers quote those numbers too. The providers below actually sell the thing that produced them.
Why Brand-Name Matters More Now
Compounding a copy of a commercially available drug is broadly restricted, with a drug shortage as the main exception. That exception is what allowed compounded semaglutide and tirzepatide to flood the market — and it closed when the FDA resolved the tirzepatide shortage in October 2024 and the semaglutide shortage on 21 February 2025.
What you give up with a compounded copy is not the molecule — it is everything around it. The FDA does not review compounded preparations for safety, effectiveness or quality. Potency, sterility and consistency are not verified unless the seller commissions testing, and across every provider and supplement we have reviewed, almost none publishes it.
“Same active ingredient” is true and incomplete. Our compounded versus brand-name guide sets out the full trade.
There is a second, subtler advantage. A brand-name prescription is a known quantity — a defined dose of a defined product. Several compounded services we reviewed never name the molecule at all, and one sells a three-ingredient combination no trial has studied.
The Price Gap Has Narrowed
The usual reason to accept a compounded copy was cost, and that argument is weaker than it was. Manufacturer-direct self-pay routes now put brand-name semaglutide within reach of the mid-market compounded tier, and several telehealth services publish brand-name prices openly — Measured lists Wegovy and Zepbound ranges on the page.
The gap has not closed — the cheapest compounded routes we found are $86 and $88.65 a month, well below any brand-name option. But it is now a difference you can weigh rather than an impossible choice, particularly if you have insurance that could cover the approved product. See our insurance-billing providers.
The Providers
Ranked by our editorial rating. Every provider below offers FDA-approved brand-name medication; several also offer compounded options alongside, which their individual reviews cover.
Imbue Health
From $149/month — brand-name Foundayo or oral Wegovy, plus a flat $29/month membership; Zepbound KwikPen from $299
Our editorial rating: 4.6 / 5
100% brand-name FDA-approved GLP-1s at prices that compete with the compounded market.
Stands out for: Brand-name medication from $149/month, plus a published Medicare pathway at $79/month all-in.
Main caveat: The $299 Zepbound figure may be a starting-dose price — confirm before committing.
- Membership: $29/month, flat, no contracts
- Insurance: Not accepted
- Availability: All 50 states plus DC
LillyDirect
From $299/month — Zepbound self-pay at 2.5 mg, rising to $449 at maintenance doses; Foundayo from $149
Our editorial rating: 4.5 / 5
Eli Lilly's own direct-to-patient pharmacy selling brand-name Zepbound and Mounjaro self-pay.
Stands out for: The first realistic cash-pay route to brand-name tirzepatide, with prior-authorization assistance.
Main caveat: You must bring your own prescriber, and the price rises to $449 at maintenance doses.
- Membership: None — pharmacy purchase, no subscription
- Insurance: Accepted
- Availability: Not published
NovoCare Pharmacy
From $149/month — brand-name Wegovy or Ozempic pill; $199 for the pen
Our editorial rating: 4.5 / 5
Novo Nordisk's own direct-to-patient pharmacy selling brand-name Wegovy and Ozempic on a cash-pay basis.
Stands out for: FDA-approved brand-name semaglutide at a price that undercuts much of the compounded market.
Main caveat: You must bring your own prescription and prescriber; semaglutide only, no tirzepatide.
- Membership: None — pharmacy purchase, no subscription
- Insurance: Accepted
- Availability: Not published
Amazon One Medical
From $149/month — cash-pay for oral Wegovy or Foundayo, or from $25/month with insurance coverage; injectables from $299 cash. Ranked on the cash price for comparability
Our editorial rating: 4.5 / 5
Brand-name only, insurance accepted, and the prescription attached to real primary care - the strongest structural proposition we have reviewed.
Stands out for: Shows insurance and cash prices side by side at checkout, and clinicians can manage related conditions such as cardiovascular disease and diabetes rather than treating weight in isolation.
Main caveat: The $25 figure depends entirely on your plan covering GLP-1s for weight management, injectables at $299 cash are well above the compounded market, and the programme is too new to have a track record.
- Membership: None - One Medical membership is not required to start or schedule a visit
- Insurance: Accepted
- Availability: Not stated in the announcement we reviewed
Circle Medical
appointments $120 self-pay, or an average $0–$35 out of pocket with insurance; medication billed by your pharmacy
Our editorial rating: 4.4 / 5
An online and in-person primary care practice that accepts over 1,500 insurance plans.
Stands out for: Real insurance billing including Medicare, plus in-person clinics — unique in our review set.
Main caveat: Medication cost is separate and entirely plan-dependent; no compounded option.
- Membership: None — no memberships or other fees
- Insurance: Accepted
- Availability: Video nationwide plus 20+ physical clinics; full list not published
Midi Health
compounded doses cited from $34/week for eligible patients; medication cost depends on your plan
Our editorial rating: 4.4 / 5
An insurance-based midlife and menopause practice with real 30-minute clinician visits and pharmacy choice.
Stands out for: Genuinely insurance-billed care with no membership fee for qualifying patients.
Main caveat: Your actual cost depends entirely on your plan, and "qualifying" is not defined publicly.
- Membership: None for qualifying insured patients
- Insurance: Accepted
- Availability: Offered by employers in all 50 states
CVS Health Weight Management
From $149/month — self-pay for an FDA-approved GLP-1 using a manufacturer voucher; as low as $25 with eligible commercial insurance, or $50 on the CMS Medicare Bridge program through 31 December 2027. Clinic visits are $29 each with no membership.
Our editorial rating: 4.4 / 5
FDA-approved brand-name GLP-1 medication at prices that compete with the compounded market, with nothing to cancel.
Stands out for: At $149 self-pay it undercuts LillyDirect by half, drops to $25 for eligible insured patients, and puts a pharmacist behind a counter you can actually talk to.
Main caveat: The low prices depend on manufacturer programs with eligibility conditions, the Medicare route expires at the end of 2027, and CVS also owns the PBM that sets formulary preferences.
- Membership: None - $29 per MinuteClinic visit, no subscription
- Insurance: Accepted
- Availability: Nationwide via CVS Pharmacy and MinuteClinic
Shapely
From $99/month — compounded semaglutide; $166 tirzepatide; membership is separate
Our editorial rating: 4.3 / 5
Insurance verification first, with a cheap compounded fallback and monthly dietitian visits.
Stands out for: Checks your coverage before you commit, and includes a credentialed dietitian.
Main caveat: Only four states, and the membership fee stacks on top of medication.
- Membership: $99/month standard, promotional rates advertised
- Insurance: Accepted
- Availability: California, Florida, New York, Texas only
DrHouse
visits $129, or $19 with a $9.99/month membership; medication billed by your pharmacy
Our editorial rating: 4.3 / 5
24/7 video visits with doctors, brand-name prescriptions, and your choice of pharmacy.
Stands out for: The most complete published eligibility criteria we found, at a very low visit cost.
Main caveat: No compounded option, so medication cost is high without insurance coverage.
- Membership: $9.99/month optional, first month waived
- Insurance: Accepted
- Availability: All 50 states
knownwell
stated $31 average cost per insured visit; medication cost depends entirely on your plan
Our editorial rating: 4.3 / 5
Weight-inclusive primary care that bills commercial insurance and employs obesity medicine certified clinicians.
Stands out for: One of the few services here inside the insurance system, with real clinics in five states and a stated $31 average insured visit.
Main caveat: Claims 16% weight loss at twelve months and 97% maintenance at two years with no denominator, definition or citation, and never names the medication or its price.
- Membership: None - an insurance-billed practice rather than a subscription
- Insurance: Accepted
- Availability: Virtual nationwide; in-person clinics in California, Georgia, Illinois, Massachusetts and New York, Texas listed as coming soon
Hello Alpha
$79/month membership; medication billed separately through insurance
Our editorial rating: 4.2 / 5
Brand-name-only telehealth with the widest FDA-approved formulary and 24/7 provider messaging.
Stands out for: Publishes specific eligibility exclusions and screens for eating disorder history.
Main caveat: The membership fee is non-refundable if your prior authorization is denied.
- Membership: $79/month (Alpha Plus+)
- Insurance: Accepted
- Availability: Not published
MDLIVE
primary care visits $0 with participating insurance; medication billed by your pharmacy
Our editorial rating: 4.2 / 5
A major Evernorth-backed telehealth network that prescribes anti-obesity medications through primary care.
Stands out for: $0 visits with a participating plan — the cheapest clinician access available.
Main caveat: Not available for weight medication in four states, and prescribing is at doctor discretion.
- Membership: None
- Insurance: Accepted
- Availability: US and Puerto Rico, except FL, LA, MS, NJ for anti-obesity medication
Zealthy
From $151/month — compounded semaglutide on a quarterly plan; brand-name from $25 with insurance
Our editorial rating: 4.1 / 5
Runs both an insurance pathway to brand-name GLP-1s and a cash-pay compounded option.
Stands out for: 24/7 licensed provider access included at no extra cost, on either pathway.
Main caveat: The lowest price requires a quarterly commitment, and cancellation terms are unpublished.
- Membership: Bundled into the monthly price
- Insurance: Accepted
- Availability: Not published
Teladoc Health
access and cost depend on your employer or health plan; a discounted self-pay option is referenced
Our editorial rating: 4 / 5
A major telehealth network offering GLP-1 prescribing and support through employers and health plans.
Stands out for: A multidisciplinary team including dietitians and coaches, often at little or no cost to members.
Main caveat: Unavailable unless your employer or insurer offers it, and nothing is priced publicly.
- Membership: None direct — access comes through your employer or health plan
- Insurance: Accepted
- Availability: Not published
What to Watch For
Check which product you are actually being prescribed. Some providers list brand names and compounded versions under a single heading — we found one selling “Ozempic, Wegovy and Semaglutide” at one price, where the price itself tells you it is compounded. Ask for the product name in writing.
Note the indication. Ozempic and Mounjaro are approved for type 2 diabetes; Wegovy and Zepbound are the same molecules approved for weight management. Providers routinely list all four together. If you do not have diabetes, the weight-management approvals are the relevant ones and prescribing the diabetes versions for weight loss is off-label — worth raising explicitly.
Ask what happens at dose escalation. Brand-name pricing frequently steps up with dose, and a quoted starting price may describe only your first month. Our GLP-1 cost guide covers converting any quote to an annual figure.
Medical Disclaimer & Review Date
This review is general consumer information, not medical advice. GLP-1 medications are prescription drugs with serious contraindications, and whether any treatment is appropriate for you is a decision only a licensed healthcare provider who knows your medical history can make. Nothing here should be used to start, stop, or change a medication.
Details in this review come from the providers listed's own published materials as of the date below. Pricing, medication availability, state coverage, and policies in this category change frequently — verify current terms directly with the provider before purchasing.
Date reviewed: September 6, 2026